학술논문
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.
Document Type
journal article
Author
Nabi, Hafsah; Georgiadis, Stylianos; Loft, Anne Gitte; Hendricks, Oliver; Jensen, Dorte Vendelbo; Andersen, Marlene; Chrysidis, Stavros; Colic, Ada; Danebod, Kamilla; Hussein, Mohamad Redha; Kalisz, Maren Høgberget; Kristensen, Salome; Lomborg, Niels; Manilo, Natalia; Munk, Heidi Lausten; Pedersen, Jens Kristian; Raun, Johnny Lillelund; Mehnert, Frank; Krogh, Niels Steen; Hetland, Merete Lund
Source
Annals of the Rheumatic Diseases; Nov2021, Vol. 80 Issue 11, p1400-1409, 10p
Subject
Language
ISSN
00034967
Abstract
Copyright of Annals of the Rheumatic Diseases is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)